Human papillomavirus vaccine: safe, effective, underused
- PMID: 23288945
- DOI: 10.3949/ccjm.80a.12084
Human papillomavirus vaccine: safe, effective, underused
Abstract
Vaccination against human papillomavirus (HPV) is safe and effective. It is recommended for females age 9 to 26 and for males age 11 to 26, yet vaccination rates are low. We review the host immune response, the data behind the recommendations for HPV vaccination, and the challenges of implementing the vaccination program.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources